Skip to main content
. 2018 Aug 31;11:5371–5381. doi: 10.2147/OTT.S170775

Figure 6.

Figure 6

Proposed model for STARD13 inhibiting HCC cell stemness, enhancing drug resistance.

Notes: STARD13 acts as a potential inhibitor of YAP transcriptional activity by blocking RhoA–F-actin signaling cascade through its Rho GTPase activity. This inhibition inhibits HCC stemness, thus enhancing drug sensitivity.

Abbreviations: F-actin, filamentous actin; HCC, hepatocellular carcinoma; STARD13, StAR-related lipid transfer domain 13.